St. Jude Children's Research Hospital: Neoplasms trials

The registry lists 65 Neoplasms studies with St. Jude Children's Research Hospital as lead sponsor. 9 are open to participants now and 11 have results posted.

Phase 1 15Phase 2 14Phase 3 3No phase 35(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Revealing Information Genuinely & Honestly Across Time - Communication Preferences VisitRecruitingNCT06993688Not applicable
• Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia SurvivorsRecruitingNCT06819475Not applicable
• Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and LymphomaRecruitingNCT06747910Not applicable
• Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor PatientsRecruitingNCT05468359Phase 1/2
• Response to Influenza Vaccination in Pediatric Oncology PatientsRecruitingNCT05384288
• Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing SarcomaRecruitingNCT04901702Phase 1/2
• Childhood Cancer Survivor StudyRecruitingNCT01120353
• Establishment of a Lifetime of Cohort of Adults Surviving Childhood CancerRecruitingNCT00760656
• Protocol For Collecting Data On Patients With Childhood CancerRecruitingNCT00684580
• Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer SurvivorsActive, not recruitingNCT06053268Not applicableResults posted
• Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric CancerCompletedNCT05746429Not applicableResults posted
• eHealth Insomnia Intervention for Adult Survivors of Childhood CancerCompletedNCT04317742Not applicableResults posted
• Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior TransplantationTerminatedNCT02259348Phase 2Results posted
• Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative RegimenTerminatedNCT02199041Phase 2Results posted
• Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin LymphomaActive, not recruitingNCT01920932Phase 2Results posted
• Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime CohortCompletedNCT01700959Phase 3Results posted
• T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic TransplantTerminatedNCT01621477Phase 2Results posted
• Umbilical Cord Blood Transplantation In Patients With Hematologic Malignancies Using A Myeloablative Preparative RegimenCompletedNCT01328496Phase 2Results posted
• Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological MalignanciesCompletedNCT00566696Phase 2Results posted
• A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side EffectsCompletedNCT00187226Phase 2Results posted
• Multi-component Remote Assessment in Adult Survivors Using a Connected Technology Platform for Healthcare DeliveryWithdrawnNCT07222358
• Remote Exercise Video Adaptations to Maximize Physical Activity in Childhood CancerActive, not recruitingNCT06411704
• Trial of Idasanutlin and Selinexor Therapy for Children With Progressive/Relapsed AT/RT or Extra-CNS Malignant Rhabdoid TumorsWithdrawnNCT05952687Phase 1
• An Evaluation of Concordance of Smartwatch ECG and One Clinical ECG and Comparison of The Two ECGS in Terms of Predictive RisksActive, not recruitingNCT05617391
• Use of Transcranial Photobiomodulation to Improve Cognition and Self-Reported Outcomes in Survivors of Childhood CancerCompletedNCT05550948Not applicable
• Patient- Generated Health Data to Predict Childhood Cancer Survivorship OutcomesActive, not recruitingNCT05342155
• Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy RecipientsCompletedNCT05164016
• Cardiac Autonomic Dysfunction in Childhood Cancer SurvivorsWithdrawnNCT05132673
• An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood CancerActive, not recruitingNCT04733534Phase 2
• Telehealth Based Intervention to Improve Functional Capacity in Survivors of Childhood Cancer With Significantly Limited Exercise ToleranceCompletedNCT04714840Not applicable
• Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In ChildrenCompletedNCT04371315
• Social Experiences of Adolescents and Young Adults With CancerActive, not recruitingNCT04328350
• Estimating Setup Uncertainty in Pediatric Proton Therapy Using Volumetric ImagesActive, not recruitingNCT04125095
• Indocyanine Green (ICG) Guided Tumor ResectionCompletedNCT04084067Phase 1
• Patient-Reported Outcome Version of the Common Criteria for Adverse EventsActive, not recruitingNCT04050072
• Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain TumorsCompletedNCT04023669Phase 1
• Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17Active, not recruitingNCT03755804Phase 2
• SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain TumorsCompletedNCT03434262Phase 1
• Tumor Rebiopsy in Children and Adolescents With Recurrent or Progressive Solid MalignanciesCompletedNCT03276702
• Validation Study of Pediatric Patient-Reported OutcomesCompletedNCT03229837
• Next Generation Pathogen Sequencing for Prediction of Adverse EventsActive, not recruitingNCT03226158
• Evaluation of Proton Therapy in Pediatric Cancer PatientsActive, not recruitingNCT03223766
• Social Emotional Development in Young Children With CancerActive, not recruitingNCT03086421
• Understanding Communication in Healthcare to Achieve Trust (U-CHAT)CompletedNCT02846038
• Medical Treatment Decision Making Using Adaptive Conjoint AnalysisTerminatedNCT02608307
• Talazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid MalignanciesCompletedNCT02392793Phase 1
• A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood CancerActive, not recruitingNCT02256137
• Effects of Preoperative Physical Therapy in Patients With Lower Extremity MalignancyCompletedNCT01674101Not applicable
• Immune Reconstitution in Oncology Patients Following Autologous Stem Cell TransplantCompletedNCT01540175
• Adolescent Loss: The Impact of Loss on Adolescent Oncology PatientsCompletedNCT01473862
• DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem GliomaCompletedNCT00899834
• Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic MalignanciesCompletedNCT00824135Phase 1
• Radiofrequency Ablation of TumorsCompletedNCT00705497Phase 1
• Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic MalignanciesCompletedNCT00697671Phase 1
• Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid TumorsCompletedNCT00640796Phase 1
• Everolimus for Treating Pediatric Patients With Recurrent or Refractory TumorsCompletedNCT00187174Phase 1
• Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid TumorsCompletedNCT00186979Phase 1
• Determination of a Safe Dose of Optison in Pediatric Patients With Solid TumorsCompletedNCT00186953Phase 1
• Haploidentical Stem Cell Transplantation for Patients With Hematologic MalignanciesCompletedNCT00186823Phase 3
• Stem Cell Transplantation for Patients With Hematologic MalignanciesCompletedNCT00152139Phase 3
• Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and LymphomasCompletedNCT00152126Not applicable
• Haploidentical Stem Cell Transplant for Treatment Refractory Hematological MalignanciesCompletedNCT00145613Phase 2
• Stem Cell Transplantation as Immunotherapy for Hematologic MalignanciesCompletedNCT00143559Phase 2
• Oxaliplatin in Treating Children With Advanced Solid TumorsCompletedNCT00005844Phase 1
• Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary OriginCompletedNCT00004005Phase 2